Genelux (GNLX) News Today $3.92 -0.03 (-0.76%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$3.92 0.00 (0.00%) As of 09/15/2025 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GNLX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Alyeska Investment Group L.P. Acquires New Stake in Genelux Corporation $GNLXSeptember 9, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Purchases New Position in Genelux Corporation $GNLXSeptember 7, 2025 | marketbeat.comGenelux Corp. Lowers Stock Option Exercise PricesSeptember 4, 2025 | msn.comGenelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment ConferenceSeptember 3, 2025 | markets.businessinsider.comHeights Capital Management Inc. Purchases New Position in Genelux Corporation $GNLXAugust 30, 2025 | marketbeat.comGenelux Corporation (NASDAQ:GNLX) Receives Average Rating of "Buy" from AnalystsAugust 23, 2025 | marketbeat.comGenelux Q3 EPS Reduced by Brookline Capital ManagementAugust 17, 2025 | marketbeat.comGenelux Corporation Reports Q2 2025 Financial Results and Updates on Clinical Development of Olvi-VecAugust 7, 2025 | quiverquant.comQGenelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business UpdatesAugust 7, 2025 | globenewswire.comGenelux (GNLX) to Release Earnings on WednesdayAugust 7, 2025 | marketbeat.comLUCID CAPITAL MARKETS Initiates Coverage of Genelux (GNLX) with Buy RecommendationJuly 22, 2025 | msn.comGenelux Corporation (NASDAQ:GNLX) Stake Lifted by Woodward Diversified Capital LLCJuly 17, 2025 | marketbeat.comGenelux (NASDAQ:GNLX) Raised to "Hold" at Wall Street ZenJuly 12, 2025 | marketbeat.comGenelux Corporation Appoints Eric Groen as General Counsel and Head of Business DevelopmentJuly 7, 2025 | quiverquant.comQGenelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business DevelopmentJuly 7, 2025 | globenewswire.comGenelux Corporation (NASDAQ:GNLX) Receives Consensus Recommendation of "Buy" from AnalystsJuly 2, 2025 | marketbeat.comGenelux (NASDAQ:GNLX) Rating Lowered to "Sell" at Wall Street ZenJune 28, 2025 | marketbeat.comMillennium Management LLC Cuts Stake in Genelux Co. (NASDAQ:GNLX)June 11, 2025 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Given Average Recommendation of "Buy" by BrokeragesJune 7, 2025 | marketbeat.comGenelux (NASDAQ:GNLX) Downgraded by Wall Street Zen to SellJune 6, 2025 | marketbeat.comGenelux (NASDAQ:GNLX) Trading Up 3.3% - Time to Buy?June 6, 2025 | marketbeat.comHC Wainwright Forecasts Genelux's Q2 Earnings (NASDAQ:GNLX)May 11, 2025 | marketbeat.comRenaissance Technologies LLC Lowers Stock Position in Genelux Co. (NASDAQ:GNLX)May 11, 2025 | marketbeat.comGenelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business UpdatesMay 6, 2025 | globenewswire.comGenelux (GNLX) Projected to Post Earnings on ThursdayMay 3, 2025 | marketbeat.comBenchmark Co. Remains a Buy on Genelux Corp. (GNLX)April 9, 2025 | markets.businessinsider.comGuggenheim Sticks to Their Buy Rating for Genelux Corp. (GNLX)April 5, 2025 | markets.businessinsider.comGenelux Q1 EPS Lowered by Brookline Capital ManagementApril 5, 2025 | marketbeat.comHC Wainwright Forecasts Genelux's Q1 Earnings (NASDAQ:GNLX)April 5, 2025 | marketbeat.comGenelux's (GNLX) "Buy" Rating Reiterated at HC WainwrightApril 1, 2025 | marketbeat.comGenelux (NASDAQ:GNLX) Releases Earnings Results, Misses Expectations By $0.07 EPSMarch 29, 2025 | marketbeat.comResearch Analysts Set Expectations for Genelux FY2024 EarningsMarch 29, 2025 | marketbeat.comGenelux reports FY24 EPS (95c), consensus (88c)March 29, 2025 | markets.businessinsider.comGenelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 28, 2025 | globenewswire.comEquities Analysts Issue Forecasts for Genelux Q1 EarningsMarch 28, 2025 | marketbeat.comFY2024 EPS Estimates for Genelux Lifted by HC WainwrightMarch 28, 2025 | marketbeat.comGenelux (GNLX) Projected to Post Quarterly Earnings on FridayMarch 28, 2025 | marketbeat.comResearch Analysts Offer Predictions for Genelux Q1 EarningsMarch 27, 2025 | marketbeat.comGenelux announces alignment with FDA of approval pathway for Olvi-VecMarch 26, 2025 | markets.businessinsider.comGenelux's (GNLX) Buy Rating Reiterated at HC WainwrightMarch 26, 2025 | marketbeat.comGenelux, Newsoara announce preliminary Phase 1b/2 data of Olvi-VecMarch 26, 2025 | markets.businessinsider.comGenelux Corporation: Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung CancerMarch 25, 2025 | finanznachrichten.deGenelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory DiseaseMarch 25, 2025 | markets.businessinsider.comGenelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common StockMarch 25, 2025 | globenewswire.comGenelux (NASDAQ:GNLX) Stock Price Down 1.3% - Here's What HappenedMarch 22, 2025 | marketbeat.comWhy Genelux Corporation (GNLX) is Skyrocketing So Far in 2025March 2, 2025 | msn.comOne new option listing on February 19thFebruary 19, 2025 | markets.businessinsider.comGenelux Co. (NASDAQ:GNLX) Stock Position Decreased by Woodward Diversified Capital LLCFebruary 8, 2025 | marketbeat.comGenelux Brings in Arrowhead Pharmaceuticals Exec as New Finance ChiefFebruary 3, 2025 | marketwatch.comGenelux appoints new CFO as Lourie Zak departsFebruary 3, 2025 | msn.com Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNLX Media Mentions By Week GNLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼1.840.94▲Average Medical News Sentiment GNLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼11▲GNLX Articles Average Week Get the Latest News and Ratings for GNLX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Genelux and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Zevra Therapeutics News Prime Medicine News Bicycle Therapeutics News Evolus News Replimune Group News COMPASS Pathways News REGENXBIO News Arcturus Therapeutics News Compass Therapeutics News Eton Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Genelux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNLX Stock Alerts